1. Home
  2. CCB vs DBVT Comparison

CCB vs DBVT Comparison

Compare CCB & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

HOLD

Current Price

$82.29

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$19.68

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCB
DBVT
Founded
1997
2002
Country
United States
France
Employees
N/A
90
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
CCB
DBVT
Price
$82.29
$19.68
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$126.67
$32.04
AVG Volume (30 Days)
113.2K
239.2K
Earning Date
04-27-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.26
EPS
3.06
N/A
Revenue
N/A
$5,636,000.00
Revenue This Year
$96.61
$35.04
Revenue Next Year
$22.66
$2,360.78
P/E Ratio
$27.31
N/A
Revenue Growth
N/A
35.77
52 Week Low
$70.72
$7.53
52 Week High
$120.05
$26.19

Technical Indicators

Market Signals
Indicator
CCB
DBVT
Relative Strength Index (RSI) 54.38 45.29
Support Level $73.44 $18.75
Resistance Level $85.88 $23.52
Average True Range (ATR) 2.21 0.95
MACD 0.32 -0.15
Stochastic Oscillator 58.03 18.78

Price Performance

Historical Comparison
CCB
DBVT

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: